Cleared Traditional

K020140 - VOXAR'S CALCIUM SCORING PRODUCT

K020140 is an FDA 510(k) clearance for VOXAR'S CALCIUM SCORING PRODUCT, manufactured by Voxar Limited. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 12-day FDA review.

K020140 · Voxar Limited · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2002
Decision
12d
Days
Class 2
Risk

K020140 is an FDA 510(k) clearance for the VOXAR'S CALCIUM SCORING PRODUCT. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Voxar Limited (Edinburgh, Lothian, GB). The FDA issued a Cleared decision on January 28, 2002 after a review of 12 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Voxar Limited devices

FDA 510(k) Submission Details - K020140

510(k) Number K020140 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 16, 2002
Decision Date January 28, 2002
Days to Decision 12 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 107d · This submission: 12d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1490
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K020140.
IMAGEDESK
K020061 · Barco N.V. · Apr 2002
ADVANTAGE WORKSTATION 4.1
K020483 · GE Medical Systems · Feb 2002
CORONIS 3MP MEDICL FLAT PANEL DISPLAY SYSTEM
K013922 · Barco N.V. · Jan 2002
CAAS II QVA
K012475 · Pie Medical Imaging BV · Oct 2001
KODAK RADIATION ONCOLOGY SOFTWARE/ FOR ACR SYSTEMS
K012155 · Eastman Kodak Company · Aug 2001
QCU ANALYTICAL SOFTWARE PACKAGE
K011582 · Medis Medical Imaging Systems BV · Jul 2001